AMA1-C1/Alhydrogel + CpG 7909 for Malaria

NCT00344539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

BIOLOGICAL: AMA1-C1/Alhydrogel®
BIOLOGICAL: CPG 7909 Oligodeoxynucleotide (VaxImmune®)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)